Particle.news
Download on the App Store

Gabrielle Union Reframes Menopause, Promotes Awareness of Newly Approved Hot-Flash Treatment

She urges people to speak with their health care providers about options.

Overview

  • The 53-year-old told People she initially felt shamed and believed her value as a woman was diminishing.
  • She says her outlook has shifted to empowerment and she intends to talk openly about her experience.
  • Union has partnered with Bayer to raise awareness; People reports its drug Lynkluet (elinzanetant) was recently FDA-approved for moderate to severe hot flashes.
  • She encourages individualized care conversations, noting symptoms vary widely from person to person.
  • She has recalled a severe hot flash at the 2025 Met Gala and has said an anti-inflammatory diet eased some symptoms.